A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219145 Compositions and methods to modulate immune and inflammatory responses
11/04/2004	CA2526915A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2526914A1 Compositions and methods relating to stop-1
11/04/2004	CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004	CA2523260A1 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
11/04/2004	CA2523244A1 Tissue factor antibodies and uses thereof
11/04/2004	CA2522960A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	CA2522580A1 A medicament for the two-step perioperative therapy of solid tumours
11/04/2004	CA2522565A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	CA2522354A1 8beta-vinyl-11beta-(alpha-substituted)alkyl-estra-1,3,5(10)-trienes
11/04/2004	CA2522300A1 Treatment of angiotensin ii related disease
11/04/2004	CA2522079A1 Quinazoline derivatives for treatment of cancer
11/04/2004	CA2519897A1 Modulation of telomere-initiated cell signaling
11/04/2004	CA2519338A1 Antineoplastic combinations
11/04/2004	CA2518819A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	CA2518180A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/03/2004	EP1473365A1 Angiogenesis inhibitors
11/03/2004	EP1473298A1 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions
11/03/2004	EP1473293A1 Chromenon derivatives
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1473043A1 Pharmaceutical combination for the treatment of diseases involving cell proliferation, migration or apotosis of myeloma cells, or angiogenesis
11/03/2004	EP1473038A1 Method of protecting living body from foreign factor and composition therefor
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472541A1 Imaging agents and methods of imaging naaladase of psma
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472376A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
11/03/2004	EP1472375A1 Gene products differentially expressed in cancerous breast cells and their methods of use
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472337A1 Induction of tumor immunity by variants of folate binding protein
11/03/2004	EP1472287A1 Rhamnose binding protein
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472277A1 Fap-activated anti-tumor compounds
11/03/2004	EP1472276A2 Small peptides capable of modulating the function of cd66 (ceacam) family members
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472261A2 The synthesis of naturally occuring ecteinascidins and related compounds
11/03/2004	EP1472259A1 Tetrapyrrolic macrocycles as photodynamic agents
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472246A1 Oxadiazoles having antiproliferative activity
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471939A1 Delivery of neutron capture elements for neutron capture therapy
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004	EP1313732B1 Oxindole derivatives
11/03/2004	EP1278547B1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004	EP1206257B1 Use of amino acids for making medicines for treating insulin-resistance
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP0956021B1 L-beta-dioxolane uridine analogs for treating and preventing infections by ebv, vzv and hv-8
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	EP0896625B1 Recombinant ribonuclease proteins
11/03/2004	CN1543692A Apparatus for a quick release safety connector assembly
11/03/2004	CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
11/03/2004	CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes
11/03/2004	CN1543476A Methods and compounds for the targeting of protein to exosomes
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1543462A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543362A Medical products comprising a haemocompatible coating, production and use thereof
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543356A Anti-tumor agent
11/03/2004	CN1543351A Method for enhancing the effectiveness of cancer therapies
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1542136A Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine
11/03/2004	CN1542135A Preparation and use for phospholipase A2 congener from Agkistrodon blomhoffii Ussurensis of Changbai Mountains and genes encoding same
11/03/2004	CN1542132A Highly expressed recombinant virus containing human constant region all-antibody gene and its use for treating tumor
11/03/2004	CN1542020A Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof
11/03/2004	CN1542015A Preparation method and application of harmel seed alkaloid

1 ... 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 ... 2211